Cargando…

Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine

A safer treatment for toxoplasmosis would be achieved by improving the selectivity profile of novel chemotherapeutics compared to the standard therapy pyrimethamine (PYR) and sulfadiazine (SDZ). We previously reported on the identification of the compounds with imidazole-thiosemicarbazide scaffold a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Węglińska, Lidia, Bekier, Adrian, Trotsko, Nazar, Kaproń, Barbara, Plech, Tomasz, Dzitko, Katarzyna, Paneth, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518248/ https://www.ncbi.nlm.nih.gov/pubmed/36165032 http://dx.doi.org/10.1080/14756366.2022.2112576

Ejemplares similares

TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents
por: Dzitko, Katarzyna, et al.
Publicado: (2023)

Systematic Identification of Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro
por: Paneth, Agata, et al.
Publicado: (2019)

1,3,4-Thiadiazoles Effectively Inhibit Proliferation of Toxoplasma gondii
por: Węglińska, Lidia, et al.
Publicado: (2021)

4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents
por: Bekier, Adrian, et al.
Publicado: (2021)

Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro via Structure-Based Design
por: Paneth, Agata, et al.
Publicado: (2019)

Synthesis and In Vitro Anti-Toxoplasma gondii Activity of Novel Thiazolidin-4-one Derivatives
por: Trotsko, Nazar, et al.
Publicado: (2019)

1,4-Disubstituted Thiosemicarbazide Derivatives are Potent Inhibitors of Toxoplasma gondii Proliferation
por: Dzitko, Katarzyna, et al.
Publicado: (2014)

Antibacterial Activity of Fluorobenzoylthiosemicarbazides and Their Cyclic Analogues with 1,2,4-Triazole Scaffold
por: Kosikowska, Urszula, et al.
Publicado: (2020)

Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives
por: Paruch, Kinga, et al.
Publicado: (2023)

Determination of the Primary Molecular Target of 1,2,4-Triazole-Ciprofloxacin Hybrids
por: Plech, Tomasz, et al.
Publicado: (2015)

In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds
por: de Lima Bessa, Gabriella, et al.
Publicado: (2023)

Studies on the Anticonvulsant Activity and Influence on GABA-ergic Neurotransmission of 1,2,4-Triazole-3-thione-Based Compounds
por: Plech, Tomasz, et al.
Publicado: (2014)

Thiazoles with cyclopropyl fragment as antifungal, anticonvulsant, and anti-Toxoplasma gondii agents: synthesis, toxicity evaluation, and molecular docking study
por: Łączkowski, Krzysztof Z., et al.
Publicado: (2018)

Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-Toxoplasma gondii activities of 2,4-diaminotriazine-thiazole derivatives
por: Łączkowski, Krzysztof Z., et al.
Publicado: (2018)

Synthesis and Antibacterial Activity of New Thiazolidine-2,4-dione-Based Chlorophenylthiosemicarbazone Hybrids
por: Trotsko, Nazar, et al.
Publicado: (2018)

Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles
por: Arafa, Fadwa M, et al.
Publicado: (2023)

Synergistic Effects of Thiosemicarbazides with Clinical Drugs against S. aureus
por: Chudzik-Rząd, Beata, et al.
Publicado: (2020)

Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate
por: Kaproń, Barbara, et al.
Publicado: (2017)

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy
por: Kaproń, Barbara, et al.
Publicado: (2020)

Toxoplasma gondii Myocarditis after Adult Heart Transplantation: Successful Prophylaxis with Pyrimethamine
por: Strabelli, Tania Mara V., et al.
Publicado: (2012)

Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters
por: Doliwa, Christelle, et al.
Publicado: (2013)

Pathogenicity and phenotypic sulfadiazine resistance ofToxoplasma gondii isolates obtained from livestock in northeastern Brazil
por: Oliveira, Claudio BS, et al.
Publicado: (2016)

Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case–control study
por: Reiter-Owona, Ingrid, et al.
Publicado: (2020)

4-Arylthiosemicarbazide Derivatives as Toxoplasmic Aromatic Amino Acid Hydroxylase Inhibitors and Anti-inflammatory Agents
por: Bekier, Adrian, et al.
Publicado: (2022)

Behavioral changes in mice caused by Toxoplasma gondii invasion of brain
por: Gatkowska, Justyna, et al.
Publicado: (2012)

Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties
por: Trotsko, Nazar, et al.
Publicado: (2018)

Influence of Thiazolidine-2,4-Dione Derivatives with Azolidine or Thiosemicarbazone Moieties on Haemophilus spp. Planktonic or Biofilm-Forming Cells
por: Trotsko, Nazar, et al.
Publicado: (2019)

Identification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE)()
por: Doliwa, Christelle, et al.
Publicado: (2013)

Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity
por: Bekier, Adrian, et al.
Publicado: (2021)

Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: A pilot study
por: Balaskas, Konstantinos, et al.
Publicado: (2012)

Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives
por: Trotsko, Nazar, et al.
Publicado: (2017)

Microbiologically active Mannich bases derived from 1,2,4-triazoles. The effect of C-5 substituent on antibacterial activity
por: Plech, Tomasz, et al.
Publicado: (2012)

Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells
por: Dzitko, Katarzyna, et al.
Publicado: (2015)

Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil
por: Silva, Letícia Azevedo, et al.
Publicado: (2017)

Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine
por: Sina, Sekandarpour, et al.
Publicado: (2021)

Toxoplasma gondii
por: Liesenfeld, Oliver
Publicado: (2009)

Experimental Models of Ocular Infection with Toxoplasma Gondii
por: Dukaczewska, Agata, et al.
Publicado: (2015)

Toxoplasma gondii Recombinant antigen AMA1: Diagnostic Utility of Protein Fragments for the Detection of IgG and IgM Antibodies
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

Teicoplanin-Modified HPLC Column as a Source of Experimental Parameters for Prediction of the Anticonvulsant Activity of 1,2,4-Triazole-3-Thiones by the Regression Models
por: Flieger, Jolanta, et al.
Publicado: (2020)

Host Cell Egress and Invasion Induce Marked Relocations of Glycolytic Enzymes in Toxoplasma gondii Tachyzoites
por: Pomel, Sebastien, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ap5qmc586bqa6luha3jfmrbhb1